ANIK Q2 2025 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$28M-8.2% YoY

Gross Profit

$14M50.9% margin

Operating Income

-$4M-14.8% margin

Net Income

-$4M-14.1% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

-$189,000

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$188M

Total Liabilities

$40M

Stockholders' Equity

$148M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$31M	-8.2%
Gross Profit	$14M	$20M	-29.9%
Operating Income	-$4M	-$2M	-130.9%
Net Income	-$4M	-$88,000	-4411.4%

Geographic Segments

UNITED STATES

$18M79%

Europe

$5M21%